RE:RE:RE:RE:RE:RE:afternoon sellf off is coming. aph and cmed are strong buysRacetub wrote: CMED a pump and dump? I don't think so.
Cannimed's IPO kinda flopped, but being one of the most established producers in the market with approx 6 million in revenues last quarter, I would say it's a reasonable buy right now with just a market cap around 230 million. Some people can't get over a share price of $11. They don't understand that CMED's fully diluted share count is only 25 million.
Despite massive hype, Emblem's IPO also flopped, and look at the recovery the past week. Probably the best gains in the canadian sector.
Anyway, enough about CMED.
Aurora's close is north of the middle bollinger band and we're looking at a possible bull break this week. The short report is due tomorrow, and we'll likely see a ton of the previous 10 million shares covered. Things are looking good for a run in the short term. GLTA
How do you figure EMC's IPO was a flop? The subscription receipt was issued at $1.15 which included a half warrant, full warrant being convertible at $1.75 until 2019. The share price hasn't come close to either level since Sabre became Emblem.